Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Improving specificity, destroying the ability to transport to tumors, maintaining low toxicity, and stabilizing serum are key challenges when employing antimicrobial peptides to treat breast cancer
Refrigeration of the product may cause darkening of the solution due to the riboflavin content
Cost considerations Pharmaceutical semaglutide (Wegovy): $1,300-1,500/month without insurance Insurance may cover (varies) Patient assistance programs available Research semaglutide: $150-300/month No insurance No patient assistance User assumes risk Research cagrilintide: $200-400/month Not prescription available yet Higher cost due to limited availability Total CagriSema combination cost (research chemicals): $350-700/month Both peptides at full dose Significant investment Compare to bariatric surgery ($15,000-25,000 upfront) Budget planning: Year 1 (titration + maintenance): $4,200-8,400 Ongoing maintenance: $350-700/month Consider reducing to maintenance doses May need 12-24+ months total Use our peptide cost calculator to budget protocols
Supplier Verification : Working with established suppliers who provide comprehensive testing documentation and quality assurance
NSAIDs: Non-Steroidal Anti-Inflammatory Drugs
US$ 27.67
US$ 27.65
US$ 23.30
US$ 24.42
US$ 26.61
US$ 27.71
US$ 27.11
US$ 26.60
US$ 28.76
US$ 25.78
